1. Home
  2. MDV vs CRBU Comparison

MDV vs CRBU Comparison

Compare MDV & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$18.00

Market Cap

187.5M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.66

Market Cap

167.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
CRBU
Founded
2015
2011
Country
United States
United States
Employees
9
N/A
Industry
Transportation Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.5M
167.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MDV
CRBU
Price
$18.00
$1.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$18.00
$10.75
AVG Volume (30 Days)
55.5K
1.9M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
7.50%
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.63
Revenue Next Year
$8.56
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.80
$1.22
52 Week High
$18.83
$3.53

Technical Indicators

Market Signals
Indicator
MDV
CRBU
Relative Strength Index (RSI) 50.81 36.78
Support Level $17.60 $1.39
Resistance Level $18.75 $1.73
Average True Range (ATR) 0.37 0.14
MACD -0.13 -0.03
Stochastic Oscillator 30.33 13.01

Price Performance

Historical Comparison
MDV
CRBU

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in, and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from the company's consolidated real estate properties.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: